Home›Companies›Biotech & Pharma›Selva Nexus

Selva Nexus, Inc.

Microbial evolution technology for researchers developing useful microbes.

Updated Nov 10, 2026·Latest SEC filing Apr 23, 2026·Suggest an edit

About Selva Nexus

Selva Nexus is a private company based in Albuquerque, New Mexico, incorporated in 2023 in Delaware. It has reported $50,000 raised in one offering on Form D since April 2026. Its chief executive is Alexander Washburne.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 10, 2026Apr 23, 2026$50,000of $750K target1$50,000Equity, OptionsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Selva Nexus's Form D filed Apr 23, 2026.

Nicholas Spassil
Nicholas Spassil
COO & Co-Founder, director
Alexander Washburne
Alexander Washburne
CEO & Co-Founder, director
Weston Ross
Weston Ross
CTO & Co-Founder, director

Sources

  1. SECSelva Nexus, Inc. filing history
  2. CompanySelva Nexus founders